Venture firms SV Life Sciences and Kleiner Perkins Caulfield & Byers invest in first close of $25m Series B financing for biotech company Juvaris BioTherapeutics

Sorry, you need to subscribe to read this article.

If you would like to access this article you must become a Premium Subscriber.

Premium subscribers receive complete access to our daily breaking news, premium stories, weekly Fundraising & IR Review, Knowledge Bank and LP profiles - all which are accessible via our mobile platform.

Subscribe below or contact customerservice@altassets.net